Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$4.9 - $7.12 $355,847 - $517,068
-72,622 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$6.43 - $9.86 $218,195 - $334,589
-33,934 Reduced 31.85%
72,622 $528,000
Q1 2020

May 15, 2020

BUY
$6.36 - $10.05 $677,696 - $1.07 Million
106,556 New
106,556 $740,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Barrow Hanley Mewhinney & Strauss LLC Portfolio

Follow Barrow Hanley Mewhinney & Strauss LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barrow Hanley Mewhinney & Strauss LLC, based on Form 13F filings with the SEC.

News

Stay updated on Barrow Hanley Mewhinney & Strauss LLC with notifications on news.